Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248118 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT00248118 is a Phase 2 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 72 participants.
The verdict
NCT00248118, a Phase 2 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to determine: 1) the short-term clinical efficacy and safety of bupropion for helping adolescent tobacco smokers quit, and 2) The role of withdrawal symptoms in the maintenance of smoking in adolescents.
Interventions
- DRUG Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00248118
The ClinicalTrials.gov registry entry for NCT00248118 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupropion is the first listed.
NCT00248118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00248118 about?
NCT00248118 is a clinical study titled "Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking". The purpose of this study is to determine: 1) the short-term clinical efficacy and safety of bupropion for helping adolescent tobacco smokers quit, and 2) The role of withdrawal symptoms in the maintenance of smoking in adolescents.
What is the current status of trial NCT00248118?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2005-01. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00248118?
The interventions under investigation include: Bupropion (DRUG).
Who is sponsoring clinical trial NCT00248118?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.